Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017

IF 1.6 Q4 ONCOLOGY
Lidia Biniam Medhin, L. A. Tekle, Daniel T. Fikadu, Danait Beraki Sibhatu, S. GebreYohans, K. H. Gebremichael, T. M. Halki, S. M. Said, Y. T. Ghidei, H. Lobeck
{"title":"Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017","authors":"Lidia Biniam Medhin, L. A. Tekle, Daniel T. Fikadu, Danait Beraki Sibhatu, S. GebreYohans, K. H. Gebremichael, T. M. Halki, S. M. Said, Y. T. Ghidei, H. Lobeck","doi":"10.1155/2019/8536548","DOIUrl":null,"url":null,"abstract":"In Africa, breast cancer closely compares with cervical cancer as the most common malignancy affecting women and the incidence rates appear to be rising. Eritrea is experiencing a growing breast cancer problem, but little is presently known on tumor patterns, breast cancer epidemiology, and risk factors. The main objective of this study is to provide baseline data on breast cancer incidence in both sexes in Eritrea. This study was carried out retrospectively and quantitatively by collecting, abstracting, analyzing, coding, and interpreting data recorded in National Health Laboratory (NHL) using CanReg5 ver. 5.00.35. Extracting and classification of the tumor data was done using topography, morphology together with the ICD-10. To generate the incidence rate for the seven years the Eritrean population dataset was used from the population pyramid net for 2014. After we entered all the data from Pathology department in NHL, data was analyzed using the predetermined and developed built-in analysis tools of CanReg5 software and Microsoft Excel 2010. A total number of 9,403 pathology cases were recorded from 2011 to 2017. Out of these 1,497 cases were confirmed as cytology and histology of breast cases. From 1,497 confirmed breast cases in both sexes, the incidence of benign cases was higher than incidence of malignant cases with the case number of 1, 149, and 348, respectively. Out of the 1,497 cases, 1,447 (96.66%) were females; this included a total incidence cases of female benign and malignant breast cases 1,111 (76.78%), and 336 (23.22%), respectively. In both female and male age group the highest positive cases were found in the age greater than 85. The incidence age standard rate per 100,000 in females and male was 3.3 and 0.2, respectively. In sum, the age standardized incidence of breast cancer was relatively low. However, it is our opinion that the low prevalence may be due to low awareness and a highly centralized screening and diagnostic services. This limits access. Altogether, it is our opinion that breast cancer presents a burden to Eritrean ministry of health.","PeriodicalId":46159,"journal":{"name":"International Journal of Breast Cancer","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Breast Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/8536548","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 5

Abstract

In Africa, breast cancer closely compares with cervical cancer as the most common malignancy affecting women and the incidence rates appear to be rising. Eritrea is experiencing a growing breast cancer problem, but little is presently known on tumor patterns, breast cancer epidemiology, and risk factors. The main objective of this study is to provide baseline data on breast cancer incidence in both sexes in Eritrea. This study was carried out retrospectively and quantitatively by collecting, abstracting, analyzing, coding, and interpreting data recorded in National Health Laboratory (NHL) using CanReg5 ver. 5.00.35. Extracting and classification of the tumor data was done using topography, morphology together with the ICD-10. To generate the incidence rate for the seven years the Eritrean population dataset was used from the population pyramid net for 2014. After we entered all the data from Pathology department in NHL, data was analyzed using the predetermined and developed built-in analysis tools of CanReg5 software and Microsoft Excel 2010. A total number of 9,403 pathology cases were recorded from 2011 to 2017. Out of these 1,497 cases were confirmed as cytology and histology of breast cases. From 1,497 confirmed breast cases in both sexes, the incidence of benign cases was higher than incidence of malignant cases with the case number of 1, 149, and 348, respectively. Out of the 1,497 cases, 1,447 (96.66%) were females; this included a total incidence cases of female benign and malignant breast cases 1,111 (76.78%), and 336 (23.22%), respectively. In both female and male age group the highest positive cases were found in the age greater than 85. The incidence age standard rate per 100,000 in females and male was 3.3 and 0.2, respectively. In sum, the age standardized incidence of breast cancer was relatively low. However, it is our opinion that the low prevalence may be due to low awareness and a highly centralized screening and diagnostic services. This limits access. Altogether, it is our opinion that breast cancer presents a burden to Eritrean ministry of health.
厄立特里亚乳腺癌发病率:2011年至2017年的回顾性研究
在非洲,乳腺癌与宫颈癌密切相关,是影响妇女的最常见恶性肿瘤,发病率似乎在上升。厄立特里亚的乳腺癌问题日益严重,但目前对肿瘤模式、乳腺癌流行病学和危险因素知之甚少。本研究的主要目的是提供厄立特里亚男女乳腺癌发病率的基线数据。本研究采用回顾性和定量的方法,使用CanReg5 ver收集、提取、分析、编码和解释国家卫生实验室(NHL)记录的数据。5.00.35. 利用地形图、形态学和ICD-10对肿瘤数据进行提取和分类。为了生成7年的发病率,使用了2014年人口金字塔网的厄立特里亚人口数据集。我们输入NHL病理部门的所有数据后,使用预先开发的内置分析工具CanReg5软件和Microsoft Excel 2010对数据进行分析。2011 - 2017年共记录病理病例9403例。其中1497例经细胞学和组织学证实为乳腺病例。在1497例确诊的男性和女性乳房病例中,良性病例的发生率高于恶性病例的发生率,分别为1149例和348例。1497例中,女性1447例(96.66%);其中女性良、恶性乳腺总发病率分别为1111例(76.78%)和336例(23.22%)。在男女年龄组中,85岁以上年龄组的阳性病例最多。每10万人中女性和男性的发病年龄标准率分别为3.3和0.2。总之,乳腺癌的年龄标准化发病率相对较低。然而,我们认为低患病率可能是由于低意识和高度集中的筛查和诊断服务。这限制了访问。总之,我们认为,乳腺癌是厄立特里亚卫生部的一个负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.40
自引率
0.00%
发文量
25
审稿时长
19 weeks
期刊介绍: International Journal of Breast Cancer is a peer-reviewed, Open Access journal that provides a forum for scientists, clinicians, and health care professionals working in breast cancer research and management. The journal publishes original research articles, review articles, and clinical studies related to molecular pathology, genomics, genetic predisposition, screening and diagnosis, disease markers, drug sensitivity and resistance, as well as novel therapies, with a specific focus on molecular targeted agents and immune therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信